Solventum Corporation is a global healthcare company developing, manufacturing, and commercializing a portfolio of solutions that leverage deep material science, data science, and digital capabilities to address critical customer needs. The Company’s segments include MedSurg, Dental Solutions, and Health Information System. MedSurg is a provider of solutions including negative pressure wound therapy, advanced wound dressings, advanced skin care, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies Original Equipment Manufacturer (OEM). Dental Solutions is a provider of a comprehensive suite of dental and orthodontic products including brackets, aligners, and restorative cement. Health Information Systems provides healthcare systems with software solutions, including computer-assisted physician documentation, and direct-to-bill and coding automation.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 8.32B.
Fairly Valued
The company’s latest PE is 9.67, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 129.24M shares, decreasing 5.09% quarter-over-quarter.
Held by Nelson Peltz
Star Investor Nelson Peltz holds 7.09M shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.95.